TLR9 and neoplasm: However, there was no significant prevention of tumor development in the TLR9−/− mice (Figure 6), which are defective in IgG production (Figure 6A), after immunization with the complex of hTM4SF5R2-3 peptide and Lipoplex(O) [28].